Xanodyne Pharmaceuticals Balance Sheet
View: Annual
| Assets | Dec 06 | Dec 05 | Dec 04 |
|---|---|---|---|
| Current Assets | |||
| Cash | 11.7 | 14.7 | -- |
| Net Receivables | 6.2 | 13.1 | -- |
| Inventories | 6.9 | 5.6 | -- |
| Other Current Assets | 2.1 | 6.3 | -- |
| Total Current Assets | 26.9 | 39.7 | -- |
| Net Fixed Assets | 0.5 | 0.6 | -- |
| Other Noncurrent Assets | 109.0 | 119.0 | -- |
| Total Assets | 136.4 | 159.3 | -- |
| Liabilities and Shareholder's Equity | Dec 06 | Dec 05 | Dec 04 |
| Current Liabilities | |||
| Accounts Payable | 6.5 | 4.9 | -- |
| Short-Term Debt | 0.0 | 0.0 | -- |
| Other Current Liabilities | 16.3 | 13.3 | -- |
| Total Current Liabilities | 22.8 | 18.3 | -- |
| Long-Term Debt | 55.0 | 55.0 | -- |
| Other Noncurrent Liabilities | 0.0 | 0.0 | -- |
| Total Liabilities | 77.8 | 73.3 | -- |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | 58.6 | 86.0 | -- |
| Total Equity | 58.6 | 86.0 | -- |
| Shares Outstanding (mil.) | 0.0 | 0.0 | 0.0 |
